Pitocin
PreclinicalSmall molecule
Pitocin is one of 45 small molecule programs targeting Function. It is currently in Preclinical.
1
Indications
7
Total Trials
1
Active Trials
44
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
55 competitors in Function
#DrugCompanyPhaseTrials
1Indocin
CCosette Pharmaceuticals, Inc.
Approved
Flomax
SanofiPhase 3
Taxol
TevaPhase 2
N-Acetyl Cyteien
SStanford University
Phase 3
Ezallor Sprinkle
AstraZenecaPhase 2
Platinol
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Phase 2
Paraplatin
AAvyxa
Phase 2
Tuoyi
CCoherus Oncology, Inc.
Phase 2
Xeljanz
PPrism Pharmaceuticals
Phase 2
Golytely
BayerPhase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Function1 trial
Cooling the Uterus in C-section After Dysfunctional Labor
Terminated·—·N/A·NCT02910115·8 enrolled
Induction of Labor1 trial
Foley Bulb With Low Dose Pitocin Versus Foley Bulb With a Standard Incremental Infusion Protocol for the Induction of Labor
Completed·—·Phase 4·NCT02150954·121 enrolled
Labor1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Pitocin. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details